1.81

2.84% 0.05

Fibrobiologics Inc (FBLG)

Overview News Price History Discussions Forecast

Fibrobiologics Inc stock is traded at $1.81, with a volume of 210.18K. It is up +2.84% in the last 24 hours and up +120.19% over the past month. FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

Previous Close:

$1.76

Open:

$1.73

24h Volume:

210.18K

Relative Volume:

1.27

Market Cap:

$12.05M

Revenue:

Net Income/Loss:

$-18.68M

P/E Ratio:

-0.2448

EPS:

-7.3948

Net Cash Flow:

$-15.70M

1W Performance:

+25.69%

1M Performance:

+120.19%

6M Performance:

-75.91%

1Y Performance:

-84.76%

1-Day Range:

$1.71

$1.90

1-Week Range:

$1.401

$2.1999

52-Week Range:

$0.6201

$12.40

Fibrobiologics Inc Stock (FBLG) Company Profile

Name

Fibrobiologics Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

281-671-5150

Address

455 E. MEDICAL CENTER BLVD, HOUSTON

Employee

Twitter

Next Earnings Date

2026-07-30

Latest SEC Filings

FBLG's Discussions on Twitter

Compare FBLG vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FBLG Fibrobiologics Inc	1.81	8.59M	0	-18.68M	-15.70M	-7.3948
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-12-24	Initiated	Rodman & Renshaw	Buy
Oct-30-24	Initiated	H.C. Wainwright	Buy
Sep-24-24	Initiated	Maxim Group	Buy

Fibrobiologics Inc Stock (FBLG) Latest News

Aug 20, 2026

FibroBiologics receives Australian patent for disc disease therapy - Investing.com

Aug 20, 2026

FibroBiologics receives Australian patent for disc disease therapy By Investing.com - Investing.com Canada

Aug 20, 2026

FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease - Morningstar

Aug 20, 2026

Hundreds of millions face disc disease; FibroBiologics' patent pairs cannabidiol and cell therapy - Stock Titan

Aug 20, 2026

Aug 19, 2026

FibroBiologics Says Preclinical Data Shapes Design of Further Studies for Degenerative Joint Treatment - Sahm

Aug 19, 2026

Aug 18, 2026

FibroBiologics reports cartilage repair in animal study By Investing.com - Investing.com South Africa

Aug 18, 2026

FibroBiologics reports cartilage repair in animal study - Investing.com

Aug 18, 2026

Animal joints showed cartilage repair within four weeks of one injection - Stock Titan

Aug 18, 2026

BRIEF-Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints - Bitget

Aug 18, 2026

Aug 14, 2026

Armistice Capital discloses 9.99% FibroBiologics (FBLG) stake via Master Fund - Stock Titan

Aug 14, 2026

Aug 13, 2026

FibroBiologics Inc - Smartkarma

Aug 13, 2026

Aug 12, 2026

FBLG Q2 2026 Earnings: Narrower Loss Beats Estimates as Pre-Revenue Biotech Advances Fibroblast Pipeline - vinanet.vn

Aug 12, 2026

FBLG Q2 2026 Earnings: Narrower-Than-Expected Loss Drives 7.77% Share GainEarnings Surprise Stocks - vinanet.vn

Aug 12, 2026

FibroBiologics receives patent for islet transplant method By Investing.com - Investing.com UK

Aug 12, 2026

Aug 11, 2026

FibroBiologics (FBLG) Holds at $0.98 as Biotech Stock Tests Key Trading RangeFibonacci Extension - vinanet.vn

Aug 10, 2026

Aug 08, 2026